PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Bioinformatics, Nanjing Medical University, Nanjing, China.\', \'Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.\', \'Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China.\', \'Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, China.\', \'Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.\', \'Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.\', \'Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China.\', \'Laboratory Medicine Center, the Second Affiliated Hospital, Nanjing Medical University, Nanjing, China. yanhong@njmu.edu.cn.\', \'COVID-19 Research Center, Institute of Laboratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China. xiaxynju@163.com.\', \'Department of Laboratory Medicine & Blood Transfusion, Wuhan Huoshenshan Hospital, Wuhan, China. xiaxynju@163.com.\', \'Joint Expert Group for COVID-19, Wuhan Huoshenshan Hospital, Wuhan, China. xiaxynju@163.com.\', \'Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China. yongji@njmu.edu.cn.\', \'Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, China. yongji@njmu.edu.cn.\', \'State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China. yongji@njmu.edu.cn.\', \'Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China. hongshanchen@njmu.edu.cn.\', \'Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, China. hongshanchen@njmu.edu.cn.\', \'Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China. hongshanchen@njmu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13054-021-03555-z
?:hasPublicationType
?:journal
  • Critical care (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 33902676
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Implications of cardiac markers in risk-stratification and management for COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33902676>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33902676>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all